TWA
MNTA

TCI Wealth Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

TCI Wealth Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-127
Closed -$4K – 1728
2020
Q2 		$4K Hold
127
– – ﹤0.01% 857
2020
Q1 		$3K Buy
127
+14
+12% +$390 ﹤0.01% 955
2019
Q4 		$2K Buy
113
+34
+43% +$544 ﹤0.01% 1261
2019
Q3 		$1K Sell
79
-40
-34% -$483 ﹤0.01% 1458
2019
Q2 		$1K Hold
119
– – ﹤0.01% 1378
2019
Q1 		$2K Hold
119
– – ﹤0.01% 1118
2018
Q4 		$1K Buy
119
+33
+38% +$459 ﹤0.01% 1385
2018
Q3 		$2K Sell
86
-26
-23% -$703 ﹤0.01% 1126
2018
Q2 		$2K Buy
112
+39
+53% +$837 ﹤0.01% 1199
2018
Q1 		$1K Hold
73
– – ﹤0.01% 1297
2017
Q4 		$1K Hold
73
– – ﹤0.01% 1324
2017
Q3 		$1K Hold
73
– – ﹤0.01% 1261
2017
Q2 		$1K Hold
73
– – ﹤0.01% 1279
2017
Q1 		$1K Hold
73
– – ﹤0.01% 1226
2016
Q4 		$1K Sell
73
-67
-48% -$885 ﹤0.01% 1291
2016
Q3 		$2K Buy
140
+67
+92% +$788 ﹤0.01% 1034
2016
Q2 		$1K Buy
+73
New +$753 ﹤0.01% 1212

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

TCI Wealth Advisors's MNTA Position: Q3 2020 in Review

TCI Wealth Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 127 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in MNTA in Q2 2016 and held it in 17 quarters. The position peaked at $4K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • TCI Wealth Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • TCI Wealth Advisors sold 127 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $4K.
  • TCI Wealth Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 17 quarters.
  • TCI Wealth Advisors's Momenta Pharmaceuticals, Inc. position peaked at $4K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on TCI Wealth Advisors's 13F filing for Q3 2020, filed 20 Oct 2020.